BioCentury
ARTICLE | Clinical News

C16G2: Completed Phase I enrollment

February 25, 2013 8:00 AM UTC

C3 Jian completed enrollment of 36 healthy volunteers in a double-blind, dose-escalation, U.S. Phase I trial to evaluate a single oral rinse of C16G2. ...